Aspirin?s anti-clotting effect doesn?t work in some cases
Tuesday, May 6, 2003 By CAROLYN SUSMAN Cox News Service
Millions of Americans rely on an aspirin a day to help keep heart attacks and strokes away. But a new study in the Journal of the American College of Cardiology shows that some people are resistant to the drug?s anti-clotting effect, and they may have a threefold higher risk of death, heart attack or stroke.
?Probably there has been no medicine that has had a greater impact in our field than aspirin, but we took for granted that it worked in everyone,? said Dr. Eric Topol of the Cleveland Clinic Foundation.
?We have to increasingly appreciate that aspirin resistance is real and not turn our backs on it,? he said. ?And we need to hunt this thing down: the cause, the specific ways to more rapidly screen for it, find its genetic basis ? which is only a theory at the moment ? and protect these patients. They are taking aspirin, but they are not deriving benefit from it. So there are a lot of people out there who have the illusion of being protected by aspirin.?
The researchers enrolled 326 patients between January 1997 and September 1999 who had a history of cardiovascular disease but were stable at the time they joined the study. Based on blood tests performed after each patient had been taking 325 mg of aspirin for at least a week, 17 patients (5.2 percent) were found to be resistant to the anti-clotting effect of aspirin. (Typical aspirin therapy uses 81 mg or 162 mg of aspirin daily.)
During an average follow-up period of almost two years, aspirin-resistant patients were more than three times as likely to die or suffer a heart attack or stroke.
If aspirin resistance is related to a genetic mutation, an inexpensive genetic screening test might be possible, but first researchers would need to find the right gene.